Nanochon Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 22

Nanochon General Information

Description

Developer of medical devices and other technology intended to treat joint injuries and diseases. The company's devices replace lost and damaged cartilage and encourage new tissue growth, enabling medical practitioners to access cost-effective and on-demand devices that improve outcomes in young and active patients with knee damage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7144 13th Place Northwest
  • Suite 2200
  • Washington, DC 20012
  • United States
+1 (703)
Primary Industry
Therapeutic Devices
Other Industries
Other Commercial Products
Corporate Office
  • 7144 13th Place Northwest
  • Suite 2200
  • Washington, DC 20012
  • United States
+1 (703)

Nanochon Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanochon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Accelerator/Incubator 29-May-2024 Completed Clinical Trials - Phase 1
14. Seed Round 06-May-2024 Completed Clinical Trials - Phase 1
13. Accelerator/Incubator 16-Apr-2024 Completed Clinical Trials - Phase 1
12. Grant 01-Nov-2023 Completed Clinical Trials - Phase 1
11. Seed Round 20-Sep-2023 Completed Clinical Trials - Phase 1
10. Grant 01-Nov-2022 Completed Generating Revenue
9. Seed Round 01-Oct-2021 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
7. Accelerator/Incubator 15-May-2019 Completed Generating Revenue
6. Accelerator/Incubator 22-Jun-2018 Completed Generating Revenue
To view Nanochon’s complete valuation and funding history, request access »

Nanochon Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed Prime
Seed Preferred
To view Nanochon’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nanochon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices and other technology intended to treat joint injuries and diseases. The company's devices r
Therapeutic Devices
Washington, DC
3 As of 2024

Kfar Saba, Israel
 

Bedford, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanochon Competitors (5)

One of Nanochon’s 5 competitors is CartiHeal, a Formerly VC-backed company based in Kfar Saba, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CartiHeal Formerly VC-backed Kfar Saba, Israel
Anika Therapeutics Formerly VC-backed Bedford, MA
Arthrex Private Equity-Backed Naples, FL
Vericel Corporation Cambridge, MA
Zimmer Biomet Holdings Corporation Warsaw, IN
You’re viewing 5 of 5 competitors. Get the full list »

Nanochon Patents

Nanochon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210298908-A1 Implantable scaffolds and uses thereof Pending 30-Jul-2018
EP-3829663-A4 Implantable scaffolds and uses thereof Pending 30-Jul-2018
EP-3829663-A1 Implantable scaffolds and uses thereof Pending 30-Jul-2018
US-10624750-B2 Three-dimensionally printed tissue engineering scaffolds for tissue regeneration Active 07-Aug-2016
US-20180055643-A1 Three-dimensionally printed tissue engineering scaffolds for tissue regeneration Active 07-Aug-2016 A61F2/30942
To view Nanochon’s complete patent history, request access »

Nanochon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanochon Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
Wealthing VC Fund Venture Capital Minority
Plug and Play Tech Center Accelerator/Incubator
Virginia Catalyst University
Alumni Ventures Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

Nanochon FAQs

  • When was Nanochon founded?

    Nanochon was founded in 2013.

  • Where is Nanochon headquartered?

    Nanochon is headquartered in Washington, DC.

  • What is the size of Nanochon?

    Nanochon has 3 total employees.

  • What industry is Nanochon in?

    Nanochon’s primary industry is Therapeutic Devices.

  • Is Nanochon a private or public company?

    Nanochon is a Private company.

  • What is Nanochon’s current revenue?

    The current revenue for Nanochon is .

  • How much funding has Nanochon raised over time?

    Nanochon has raised $7.81M.

  • Who are Nanochon’s investors?

    MedTech Innovator, Wealthing VC Fund, Plug and Play Tech Center, Virginia Catalyst, and Alumni Ventures are 5 of 22 investors who have invested in Nanochon.

  • Who are Nanochon’s competitors?

    CartiHeal, Anika Therapeutics, Arthrex, Vericel, and Zimmer Biomet Holdings are competitors of Nanochon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »